Electrical Stimulation for the Treatment of Glaucoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bernhard Sable, PhD
Otto-von-Guericke University Magdeburg
Principal Investigator - Jeffrey L Goldberg, MD PhD
Stanford University
Principal Investigator - Joel Schuman, MD,FACS
Wills Eye
Principal Investigator - Joeseph F Panarelli, MD
NYU- Langone
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Otto-Von-Guericke University
Magdeburg, Germany
- Byers Eye Institute
Palo Alto, California, United States
- Nyu- Langone
New York, New York, United States
- Wills Eye Hospital
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2023
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 23 Apr 2026
- Registered enrollment
- 45
- Registry id
- NCT05626491
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.